A Schedule 13G was
Filed with the SEC on · accession 0000886982-26-000476
ESPR filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 13, 2026. A Schedule 13G was filed regarding Esperion Therapeutics, Inc., indicating a passive ownership position by an institutional or other holder.
A Schedule 13G was filed regarding Esperion Therapeutics, Inc., indicating a passive ownership position by an institutional or other holder. The filing does not disclose a change in control or activist intent.
✦ Ask GOAX AI about this filing — what it means for ESPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ESPR?
Click hereESPR filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Esperion Therapeutics, Inc., indicating a passive ownership position by an institutional or other holder. The filing does not disclose a change in control or activist intent.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Get alerts when ESPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days